{
    "code": "10000827",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000827",
    "time": "2023-01-06 03:54:18",
    "許可證字號": "衛署菌疫輸字第000827號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/09\/26",
    "發證日期": "95\/09\/26",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA01000082702",
    "中文品名": "嘉喜[四價人類乳突病毒(第6,11,16,18型)基因重組疫苗]",
    "英文品名": "GARDASIL [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine]",
    "適應症": "9-26 歲女性之預防接種；預防發生疫苗所含的人類乳突病毒第6、11、16及18型所引起的子宮頸癌前期或分化不良的病變和癌症、陰道及外陰部癌前期或分化不良的病變、生殖器疣(俗稱菜花)。\r\n27 -45 歲女性之預防接種；預防發生疫苗所含的人類乳突病毒第6、11、16及18型所引起的持續性感染及第1級子宮頸上皮內贅瘤(CIN)、預防發生疫苗所含的人類乳突病毒第6及11型所引起之生殖器疣。\r\n\r\n9-26歲男性之預防接種；預防發生人類乳突病毒第6與11型所引起的生殖器疣。",
    "劑型": "271滅菌懸液注射劑",
    "包裝": "1-100支盒裝 0.5毫升注射針筒 ( 附或不附針頭 )",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "疫苗",
    "監視期限": "",
    "主成分略述": "TYPE 6 L1 PROTEIN, TYPE 11 L1 PROTEIN, TYPE 16 L1 PROTEIN, TYPE 18 L1 PROTEIN",
    "限制項目": "02輸　入 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市信義區信義路五段106號12樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0123000  MERCK SHARP &amp; DOHME LLC",
            "製造廠廠址": "770 SUMNEYTOWN PIKE, WEST POINT, PA 19486 U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥及成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FNL0016000  MERCK SHARP &amp; DOHME B.V.",
            "製造廠廠址": "WAARDERWEG 39,2031 BN,HAARLEM,THE NETHERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FUS0122100  MERCK SHARP &amp; DOHME LLC",
            "製造廠廠址": "2778 SOUTH EAST SIDE HIGHWAY ELKTON VA 22827, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1600001610",
            "成分名稱": "TYPE 6 L1 PROTEIN",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "UG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1600001620",
            "成分名稱": "TYPE 11 L1 PROTEIN",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "UG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1600001630",
            "成分名稱": "TYPE 16 L1 PROTEIN",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "UG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1600001640",
            "成分名稱": "TYPE 18 L1 PROTEIN",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "UG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Gardasil-104-09-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000827&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "GARDASIL〔Quadrivalent Human Papillomavirus (Type 6, 11, 16, 18) Recombinant Vaccine〕single dose-104-08-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000827&Seq=013&Type=8"
        }
    ]
}